Hepatitis C virus Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Geometric Deep learning Prioritization and Validation of Cannabis Phytochemicals as Anti-HCV Non-nucleoside Direct-acting Inhibitors

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does…

Freedom WaresDecember 12, 2024

Canna~Fangled Abstracts

Cannabis as antivirals

J Appl Microbiol. 2022 Dec 14;lxac036. doi: 10.1093/jambio/lxac036. Online ahead of print. Yi Lin Sea 1, Yee…

Freedom WaresDecember 14, 2022

Canna~Fangled Abstracts

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH).

J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12797. Nordmann S1,2, Vilotitch A1,2, Roux P1,2, Esterle…

Freedom WaresOctober 6, 2017

Canna~Fangled Abstracts

Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host targeting agents.

2014 Jul 22. pii: vir.0.067231-0. doi: 10.1099/vir.0.067231-0. Endocannabinoid CB1 antagonists inhibit hepatitis C virus production,…

Freedom WaresJuly 22, 2014

Canna~Fangled Abstracts

Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.

2014 Apr 2. pii: S1201-9712(14)00031-9. doi: 10.1016/j.ijid.2013.12.017. Endocannabinoid system activation contributes to glucose metabolism disorders…

Freedom WaresApril 2, 2014

Hepatitis C virus

Geometric Deep learning Prioritization and Validation of Cannabis Phytochemicals as Anti-HCV Non-nucleoside Direct-acting Inhibitors

Cannabis as antivirals

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH).

Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host targeting agents.

Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.

Recent Posts

Archives

Categories